DFG Research Unit FOR5621
Stylianos Michalakis is Spokesperson of the DFG-funded Research Unit FOR5621 - Ocular Gene Therapy (OCU-GT): Addressing the Unmet Needs in Ocular Gene Therapy.
OCU-GT was launched in 2024 and brings together leading researchers from diverse but complementary fields who are working together to advance the field of ocular gene therapy.
More info under FOR5621